title: Prurigo gestationis.
authors.forename: A
authors.initials: A
authors.lastname: Rampone
authors.forename: B
authors.initials: B
authors.lastname: Rampone
authors.forename: S
authors.initials: S
authors.lastname: Tirabasso
authors.forename: I
authors.initials: I
authors.lastname: Capuano
authors.forename: G
authors.initials: G
authors.lastname: Vozza
authors.forename: A
authors.initials: A
authors.lastname: Vozza
authors.forename: N
authors.initials: N
authors.lastname: Rampone
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000982:Antipruritics / Q000008:administration & dosage*; D002792:Cholestyramine Resin / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D011247:Pregnancy; D011248:Pregnancy Complications / Q000175:diagnosis* / Q000188:drug therapy*; D011263:Pregnancy Trimester, Third; D011446:Prospective Studies; D011537:Pruritus / Q000175:diagnosis* / Q000188:drug therapy*; D012494:Sampling Studies; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D000982:Antipruritics; D002792:Cholestyramine Resin